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Objective: Dizziness after minor head injury (mHI) is common. In some eastern countries, it is treated
with 7% sodium bicarbonate solution (SB). This prospective study evaluated the clinical efﬁcacy of SB
compared with normal saline (NS).
Material and methods: From April 2009 to April 2010, we performed a prospective observational study on
228 patients (68% female, 32% male) with acute dizziness after mHI. At the emergency physician’s
discretion, intravenous SB (1 mL/kg) in NS (250 mL) or NS (250 mL) was administered to 166 patients and
62 patients, respectively, as empiric antidizziness therapy. Outcome measures were severity of dizziness
and treatment response, which were measured by a visual analog scale. Various characteristics were
compared between treatment groups. Any continued dizziness of the patients during follow-up was also
compared with their pre-injury condition, such as prior psychiatric disorders and the presence of vertigo.
Results: The SB group had their visual analog scale scores reduced by 25.4% compared with 24.6% in the
NS group. Both groups showed a statistically signiﬁcant reduction in dizziness (p < 0.001); however, the
dizziness improvement did not differ signiﬁcantly between the two treatment groups (p ¼ 0.699). Sixty-
four patients (28.1%) suffered from continued dizziness during follow-up (mean period, 22.4  28.9
days). The prevalence of continued dizziness was higher in patients with prior psychiatric disorders,
although this was not statistically signiﬁcant (40% vs. 27.2%, p ¼ 0.276), whereas patients with prior
vertigo did not experience a higher dizziness relapse rate (27% vs. 28.2%).
Conclusions: SB and NS administrations are both effective individually when treating patients with acute
dizziness from mHI; however, both results may be attributable to the placebo effect. Therefore more
research is necessary to understand the complex conditions that determine the effects of SB on this
disorder.
Copyright  2011, Buddhist Compassion Relief Tzu Chi Foundation. Published by Elsevier Taiwan LLC.
All rights reserved.1. Introduction
Dizziness has been shown to be the most prominent symptom
of discomfort after minor head injury (mHI) and affects 74% of
patients within the ﬁrst few days. The patients also suffer vague
symptoms of disorientation, and light-headedness as well as more
concrete symptoms such as illusions of movement and imbalance.
These can be accompanied by autonomic symptoms such as nausea
or vomiting. All these symptoms give rise to inconvenience during
daily life activities. Nevertheless, most symptoms are mitigated
within 2weeks [1]. Dizziness is thought to occur when neurologicaltment of Surgery and Emer-
spital, 100 Tzyou 1st Road,
886 73208255.
. Lin).
ddhist Compassion Relief Tzu Chimotor functions and sensory balance fail to work together,
peripheral sensory modalities of the vestibular and auditory
systems are damaged, proprioceptors over the neck are injured, or
as a result of posttraumatic stress disorder [2,3].
Intravenous administrations of 7% sodium bicarbonate solution
(SB) had been used to treat Meniere patients in the past without
any negative effects [4e9]. The effect of SB on vertigo and dizziness
is attributed to a reduction of lymph hydrops in the semicircular
canals of the inner ear or degradation of blood sludge in peripheral
capillaries in the labyrinth, thereby inhibiting the neural activity of
the medial vestibular nucleus [4,5,8,9]. Chiu et al, who studied low-
dose SB (1 mL/kg) administration in animals and in a clinical trial,
demonstrated a 62% success rate for SB treatment of dizziness
induced by the peripheral vestibule organ [10,11]. Hence, SB
administration was claimed to be effective without signiﬁcant
complications in alleviating troublesome autonomic symptoms
during acute vertiginous attack. Based on these studies, someFoundation. Published by Elsevier Taiwan LLC. All rights reserved.
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Emergency Department (ED) setting for patients who have sus-
tained concussion and have dizziness; however, its clinical effec-
tiveness has not been well established.
Normal saline (NS) is a typical pharmacological placebo,
meaning that no evidence exists in the literature of its speciﬁc
activity for the condition being treated. Nevertheless, several
studies have demonstrated the signiﬁcant psychological effects of
placebos on continuous subjective outcomes and pain treatment
[12,13]. Furthermore, some of our emergency physicians prefer
using NS to treat patients with subjective feelings of dizziness.
Here, we evaluate and compare the efﬁcacy of SB and NS for the
treatment of acute dizziness after mHI at an ED.
2. Materials and methods
2.1. Patients and setting
This is a prospective observational study with chart review. This
study was approved by the Institutional Human Investigations
Committee and the Institutional Review Board of Kaohsiung
Medical University Hospital. This 1200-bed university hospital is
located in the center of a city and provides medical services for the
local population. Patients who received intravenous antidizziness
agents for acute dizziness after mHI were enrolled. Patients were
excluded if intracranial lesions were found on computed tomog-
raphy (CT), if their outcome information was incomplete after
record review, or if they received any other antidizziness medica-
tion during treatment. All received standard care at the ED in
accordance with the Advanced Trauma Life Support guidelines
published by the American College of Surgeons. A standardized
form of trauma sheet is used for every trauma patient and this
includes personal information, trauma mechanisms, physical
examinations, clinical management with laboratory data and tests,
and diagnoses at the ED. All patients were asked to return to our
outpatient clinic for follow-up within 7 days of discharge as a part
of the protocol for ED discharge.
2.2. Data collection
All clinical data, including age, gender, medications, diagnosis
on hospital admission, patient history, body weight, initial systolic
blood pressure and body temperature, injury cause, history of post-
injury vomiting and headache, and time from injury to treatment,
were retrieved from the trauma registration data set of our data
bank and the individual’s medical records by an emergency
physician. All brain CT scans in the ED and the ultimate length of
hospital staywere also reviewed. All patients’ charts were reviewed
for a period of 4 months to identify any episodes of continued
dizziness.
The duration of posttraumatic amnesia and presence of tran-
sient loss of consciousness were estimated according to the infor-
mation from patients or witnesses. We deﬁned mHI as a blunt blow
to the head resulting in posttraumatic amnesia <1 hour, initial loss
of consciousness<15 minutes, a Glasgow coma scale (GCS) score of
14e15 on ED presentation, and absence of focal neurological signs
with no intracranial lesions on brain CT [14,15]. Patients with
intracranial lesions were excluded because of the need for addi-
tional medical therapies and possible difﬁculty in obtaining correct
dizziness tests. Continued dizziness was deﬁned as documented
dizziness in the outpatient clinic; dizziness durationwas calculated
from the injury date to the date of follow-up at which no
complaints were voiced or to the date of a failure to revisit.
The mechanisms of the patients’ traumas were classiﬁed into
four subgroups: (1) motor vehicle accident-related (i.e., roadvehicle collisions), (2) assault-related (i.e., head trauma caused by
violence, including domestic violence), (3) fall-related (i.e., injuries
caused by head impact after falling), and (4) head bump related
(i.e., any other type of impact-related head trauma). All identifying
personal characteristics were removed from the original database
before analysis.
2.3. Procedures
Patients with acute dizziness after mHI who received intrave-
nous antidizziness agents at the ED were included in this study.
Eligible patients were administered empiric antidizziness treat-
ment with either intravenous SB or NS at the physician’s discretion.
Before antidizziness treatment, the patients were evaluated for
their level of dizziness using a visual analog scale (VAS) and they
graded their dizziness sensation from 1 (least severe) to 5 (most
severe). The standardized protocol in our ED to treat dizziness
patients was administration of either SB (1 mL/kg dose) in 250 mL
of NS or 250 mL of NS alone, both by slow intravenous infusion
(5 mL/min). A second VAS was used to measure patients’ dizziness
level scores at 1 hour post-treatment. Gender, age, past history,
Glasgow coma scale score, mHI cause, and presence of headache
with or without vomiting were recorded at ﬁrst examination.
Traumatic injuries to limbs, trunk, or head were also recorded in
the trauma sheet. Any radiological examination report was also
obtained. No alternative forms of antidizziness therapy were used
to treat these enrolled patients. If dizziness did not improve after
treatment, the patient was assigned bed rest for several hours in
the ED. Brain CT scans were considered to rule out intracranial
lesions. Furthermore, the patients were considered for hospital
admission and further observation. At discharge, patients were
routinely asked to visit our outpatient clinic for follow-up.
2.4. Statistical analysis
Demographic and medical data were compared and statistically
analyzed between the two treatment groups. Data were reported
using percentages, means, medians, and standard deviations,
depending on the type of variable. Categorical variables were
analyzed using c2 analysis. The difference in VAS scores between
the SB and NS groups were analyzed by repeated-measures analysis
of variance. Pearson correlation was used to calculate the relation
between continuous variables. A p value <0.05 was considered
statistically signiﬁcant. All statistical operations were performed
using SPSS 14.0 for Windows (SPSS Inc., Chicago, IL, USA).
3. Results
Two hundred and ﬁfty-six patients who came to our ED
between April 2009 and April 2010 with acute dizziness after mHI
and who received intravenous antidizziness agents were enrolled
in this study. Fig. 1 shows the disposition of the 256 potential
eligible mHI patients in our study. Twenty-eight patients (10.9%)
were excluded from analysis because 7 (2.7%) patients showed
anatomic lesions on brain CT, whereas outcome information for the
other 21 (8.2%) patients was incomplete. Ultimately, 228 patients
were included in our analyses. Of the patients, 155 (68%) were
women, and 73 (32%) were men (mean age, 36.79  17.66 years).
Eligible patients were divided into two groups according to treat-
ment with intravenous SB (n¼ 166) or NS (n¼ 62). A comparison of
characteristics and demographics showed no signiﬁcant differences
between the two treatment groups in terms of age, gender, times
from injury to treatment, hemodynamics, trauma mechanism,
length of hospital stay, and prevalence of continued dizziness
during follow-up except for the incidence of posttraumatic
Fig. 1. Disposition of the overall study population.
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Table 1).
The overall mean VAS scores pretreatment and posttreatment
were 3.00  0.87 and 1.74  0.79, respectively. Thus there was
a 1.27-point reduction in the mean VAS score in the SB group and
a 1.23-point reduction in the NS group. Both reductions were
signiﬁcant (25.4% and 24.6% reduction, respectively; p < 0.001).Table 1






Age, mean  SD (yr) 35.38  17.11 40.56  18.69 0.059b
Female, No. (%) 116 (69.9%) 39 (62.9%) 0.315a
Time to treatment, mean  SD (hr) 34.55  94.57 34.74  72.55 0.714b
Hospital LOS, mean  SD (hr) 9.96  17.01 11.47  29.37 0.631b
Posttraumatic vomiting, No. (%) 26 (15.7%) 23 (37.1%) <0.001a
Posttraumatic headache, No. (%) 71 (42.8%) 23 (37.1%) 0.439a
Brain CT scan, No. (%) 64 (38.6%) 28 (45.2%) 0.366a
Systolic blood pressure,
mean  SD (mmHg)
137.62  22.2 140.34  24.17 0.423b
Body temperature, mean  SD (C) 37.05  3 36.91  0.44 0.726b
Body weight, mean  SD (kg) 61.41  14.38 61.18  10.86 0.907b
Patient history
Depression/anxiety, No. (%) 12 (7.2%) 3 (4.8%) 0.588a
Vertigo, No. (%) 11 (6.6%) 4 (6.5%) 0.829a
Cause of head trauma
MVA-related, No. (%) 103 (62.0%) 31 (50%) 0.097a
Assault-related, No. (%) 14 (8.4%) 11 (17.7%)
Fall-related, No. (%) 24 (14.5%) 13 (21%)
Head bump related, No. (%) 25 (15.1%) 7 (11.3%)
Continued dizziness
No. of patients (%) 46 (71.9%) 18 (28.1%) 0.843a
Days, mean  SD 25.24  31.61 15.28  19.14 0.217b
CT ¼ computed tomography; LOS ¼ length of stay; MVA ¼ motor vehicle accident;
No. ¼ number; NS ¼ normal saline (0.9%); SB ¼ 7% sodium bicarbonate solution
(1 mL/kg); SD ¼ standard deviation.
a c2 analysis.
b Student’s t test.However, the VAS improvement was not signiﬁcantly higher in the
SB group than in the NS group (p ¼ 0.699). The study population
was further divided into subgroups to identify factors affecting the
outcome measure, but no signiﬁcant differences among the
subgroups related to brain CT implementation, gender, age, or
cause of head trauma were found (p value >0.05 for all) (Table 2),
indicating that the symptoms of all subgroups of patients who
received either NS or SB improved equally after treatment.
Most blunt head injuries in our study resulted from motor
vehicle accidents, assaults, head bumps, and falls. Motor vehicle
accident was the leading cause of head trauma in the study pop-
ulation (58.8%). Dizziness was found predominantly in women
(68%), whereas men suffering dizziness were younger than women
(31.86  18.02 vs. 39.11  17.06, p ¼ 0.04). However, both sexes
experienced a signiﬁcant improvement in symptoms post-
treatment, with no signiﬁcant difference between the genders.
The average length of hospital stay was 10.4  21 hours. Overall,
28% of subjects experienced continued dizziness during follow-up,
and the mean period of continued dizziness was 22.4  28.9 days.
Continued dizziness in patients with prior psychiatric problems,
such as anxiety and depression, was not signiﬁcantly higher than
that in patients without problems (40% [6 of 15] vs. 27.2% [58 of 213]
patients, respectively; p¼ 0.276). Patients with prior vertigo did not
have a signiﬁcantly higher relapse of dizziness during follow-up
than non-vertigo patients (27% [4 of 15] vs. 28.2% [60 of 213],
respectively). No adverse systemic effects were noted in our cases,
but a small number of patients felt soreness at the injection site,
which was relieved with a warm compress.
4. Discussion
The main ﬁnding of our study is that administering of either SB
or NS is an efﬁcacious treatment of alleviating dizziness related to
mHI. The SB group had their VAS scores reduced by 25.4%
compared with 24.6% for the NS group; however there was no
statistically signiﬁcant difference between the two groups.Table 2






Total (n ¼ 228) 3.00  0.87 1.74  0.79*
1. SB group vs. NS group
SB group (n ¼ 166) 3.00  0.85 1.73  0.78* 0.699
NS group (n ¼ 62) 3.00  0.86 1.77  0.79*
2. Implementation of brain CT
Yes (n ¼ 92) 2.95  0.81 1.65  0.67* 0.409
No (n ¼ 136) 3.08  0.94 1.87  0.92*
3. Gender
Man (n ¼ 73) 3.08  0.85 1.79  0.80* 0.377
Woman (n ¼ 155) 2.84  0.88 1.64  0.75*
4. Age
<18 yr/o (n ¼ 28) 2.71  0.789 1.37  0.60* 0.747
18e65 yr/o (n ¼ 181) 3.07  0.89 1.82  0.82*
>65 yr/o (n ¼ 19) 2.88  0.60 1.71  0.59*
5. Cause of head injury
MVA-related (n ¼ 134) 3.13  0.86 1.89  0.87* 0.733
Assault-related (n ¼ 25) 2.72  0.74 1.56  0.51*
Fall-related (n ¼ 37) 2.89  0.94 1.51  0.65*
Head bump-related (n ¼ 32) 2.78  0.83 1.53  0.57*
Result reported as mean  standard deviation.
*A p value 0.001 versus VAS score pretreatment by Student’s t test.
CT ¼ computed tomography; MVA ¼ motor vehicle accident; NS ¼ normal saline;
SB ¼ sodium bicarbonate; VAS ¼ visual analog scale; yr/o ¼ years old.
a Statistical differences among subgroups by repeated-measures analysis of
variance.
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solutions containing SB against dizziness in diseases that affect the
vestibular system, such as Meniere’s disease (in which dizziness is
a major symptom), data on the effectiveness of such treatments
remain limited [4e6,8e11,16]. In our study, the clinical response to
SB was compared with responses in patients treated with NS of
similar volume. We also rated the severity of subjective complaints
and treatment response using a VAS. Both therapies were efﬁca-
cious in treating dizziness related to mHI (Table 2, p < 0.001).
Dizziness is a common problem faced by busy emergency
physicians. Previous studies have reported that mHI accounts for
90% of head injuries, whereas in the Taiwanese literature, 83%e87%
head injuries have been classiﬁed as mildly severe [17e19]. Inci-
dences of posttraumatic headache and dizziness have been
reported to be as high as 90% at 1 month of post incident and
approximately 25% at 1 year of post incident or more. Once estab-
lished for more than a few weeks, symptoms often persist for
months and tend to resist treatment, although they eventually
lessen [20]. In our patients, 28.1% (64 of 228) had persistent
symptoms on follow-up at our outpatient clinic, on average for
22.4  28.9 days.
Dizziness may result from an emotional response, or it can be
a symptom of injury or disease. In previous studies, women were
more prone to have posttraumatic dizziness than men and it was
found that a history of previous psychiatric disorder is a signiﬁcant
risk factor for postconcussion syndrome [21,22]. In our study, more
women had dizziness than men after mHI; however, a history of
psychiatric disorder or vertigo was not found to be a risk factor for
continued dizziness. In an overview of postconcussion syndrome,
King noted that both biological and psychological factors affect
posttraumatic dizziness, and that patients tend to transform post-
traumatic stress disorder into physical problems [23]. Nevertheless,
differences in culture between the East and West may account for
many of these differences. Most people in Asian countries are
reluctant to consult psychologists because they think that it is
a shame on the entire family if even one family member is diag-
nosed with a psychological disease. Therefore, individuals with
psychiatric disorders might have been underestimated.
Although intravenous SB administration is thought to affect
blood gas tests, Kawabata et al reported that the mean arterial
blood PaO2 was not signiﬁcantly altered after using SB even after
the serum bicarbonate ion level did increase dose-dependently and
concomitantly with an increased pH after injection of the drug at
doses of 1 mL/kg, 2 mL/kg, and 4 mL/kg. They also reported that the
PaCO2 did not signiﬁcantly change after injection of the drug up to
2 mL/kg but that it temporarily increased after 4 mL/kg [5]. Hence,
we concluded that the 1-mL/kg dose used in our study would not
affect blood gas tests.
We chose NS in a volume of 250 mL as either a dilution of SB or
empiric antidizziness therapy for the following reasons. First, SB is
hypertonic and frequently causes irritation when administered
intravenously. Because the drug may cause soft tissue damage if it
extravasates, we routinely dilute SB in 250 mL of NS to reduce the
incidence of local adverse effects. Second, 250 mL is the smallest
volume package of NS available in our ED. Diluting to a lower SB
dose (1 mL/kg) in a larger NS volume may prolong the time of the
drug drip and resulted in insufﬁcient pharmacotherapeutic effects.
Third, a larger volume of ﬂuid administration produces higher
urinary frequency and more changes in position when going to the
toilet might exacerbate the feeling of dizziness. It is therefore
appropriate to use a smaller volume of ﬂuid under these conditions.
Although patients responded to the administration of both SB
and NS in our study, we are aware that during its natural course
dizziness after mHI might either increase or decrease. Patients
often see doctors when their complaints peak. Fluctuatingsubjective feelings may be relatively high on admission and lower
at the end of treatment, and this might be quite unrelated to the
effects of the therapy or any placebo effect. It is possible that
patients, after asking for symptom ratings post-treatment, become
sensitized to the problem under evaluation, and either deliberately
or unconsciously, attempt to affect the clinical outcome. Although
using SB for dizziness has been proved in many studies, no differ-
ence in improvement in the dizziness ratings was observed in our
study between the SB and NS groups (Table 2, p ¼ 0.699). This
implies that the effect of SB may simply be a placebo effect and
similar to the assumed placebo effect of NS. We also divided
patients into several subgroups to explore other factors that might
have affected outcome (Table 2), but no signiﬁcant differences were
observed among these subgroups, and all patients improved
regardless of treatment type.
In this study, dizziness lessened under different therapeutic
options following a short period of bed rest after injury, which
suggests that bed rest may have some palliative effect. However, in
a randomized clinical trial of 107 people, bed rest was demon-
strated to be ineffective as a means of speeding up recovery in
patients with postconcussion syndrome [24]. In our study, dizzi-
ness in 58 patients (25.4%) was not reduced more than 24 hours
after injury pretreatment, and 5 patients (8.6%) experienced
dizziness for more than 2 weeks after/of post-treatment. Therefore,
a short period of bed rest in the ED was not the cause of dizziness
improvement.
This study had several limitations. Our results represent the
experience of a single institution andmay reﬂect the characteristics
only of local patients. Thus, selection bias may have occurred.
However, our treatment groups were well matched and had similar
demographic and clinical characteristics. We did not compare
outcomes with an observation-only group and therefore the
placebo effect was not explicitly examined in this study. We
investigated patients who sought help at the ED only. Many people
with dizziness following mHI may not seek medical advice or they
might visit another facility initially or at follow-up; therefore, the
prevalence of dizziness may have been underestimated. The
absence of a follow-up record does not necessarily mean that non-
returning patients were free of dizziness. Therefore, we cannot
determine the frequency or natural history of this disorder. The
response to SB or NS may be related to patient bias, patient
expectations, and to our enrollment of patients with relatively mild
symptoms of head trauma. Thus it is difﬁcult to distinguish
between reporting bias and the placebo effect on the subjective
outcomes. Patients may report improvement when none has
occurred to please the physician.
5. Conclusion
Acute dizziness after mHI may result from various complex
interactions among anatomical and neuropsychological processes
as well as cognitiveebehavioral and environmental factors. The
present study found that both SB and NS were efﬁcacious in
reducing dizziness. However, the natural disease course, the
patients’ expectations about treatment, and other nonspeciﬁc
effects might all account for the positive response. More research
with the inclusion of an untreated control group in placebo-
controlled trials should be undertaken to better understand the
complex conditions thatmaydetermine the therapeutic effect of SB.
Acknowledgments
We thank Ching-Ying Wu for statistical consultation in data
analysis. The ﬁrst and second authors had equal contributions. We
are grateful to the participants and research staff.
Y.-C. Cheng et al. / Tzu Chi Medical Journal 23 (2011) 46e5050References
[1] Yang CC, Tu YK, Hua MS, Huang SJ. The association between the post-
concussion symptoms and clinical outcomes for patients with mild traumatic
brain injury. J Trauma 2007;62:657e63.
[2] Maskell F, Chiarelli P, Isles R. Dizziness after traumatic brain injury: overview
and measurement in the clinical setting. Brain Inj 2006;20:293e305.
[3] Hoffer ME, Balough BJ, Gottshall KR. Posttraumatic balance disorders. Int
Tinnitus J 2007;13:69e72.
[4] Noriaki T. Drug therapy for vertigo. Clinic All-round 2006;55:2519e20.
[5] Kawabata A, Kishimoto T, Ujihara H, Sasa M, Takaori S. Inhibition by intra-
venously administered sodium bicarbonate of neuronal activity in medial
vestibular nucleus neurons. Jpn J Pharmacol 1990;54:383e9.
[6] Celestino D, Cerulli N, Iannetti G, Sagliaschi G. Acid-base equilibrium in
Meniere’s disease. J Laryngol Otol 1976;90:263e75.
[7] Yazawa Y, Kitano H, Suzuki M, Tanaka H, Kitajima K. Studies of cochlear blood
ﬂow in guinea pigs with endolymphatic hydrops. ORL J Otorhinolaryngol Relat
Spec 1998;60:4e11.
[8] Furstner J. Effects of sodium bicarbonate therapy in Meniere’s disease, espe-
cially on dizziness. Orv Hetil 1956;97:185e8.
[9] Hasegawa T. The treatment of Meniere’s disease by intravenous injections of
a concentrated solution of sodium bicarbonate. Rev Laryngol Otol Rhinol
(Bord) 1960;81:617e26.
[10] Chiu SY, Young YH. Sodium bicarbonate in the treatment of acute vertiginous
attack e basic and clinical studies. J Taiwan Otolaryngol Head Neck Surg 1993;
28:133e8.
[11] Chiu SY, Young YH. Sodium bicarbonate for the therapeutic diagnosis of
acute vertiginous attack. J Taiwan Otolaryngol Head Neck Surg 1995;30:
418e22.
[12] Katz J, Finnerup NB, Dworkin RH. Clinical trial outcome in neuropathic pain:
relationship to study characteristics. Neurology 2008;70:263e72.
[13] McDonald CJ. Is the placebo powerless? N Engl J Med 2001;345:1276e7
[author reply 8e9].[14] Stiell IG, Clement CM, Rowe BH, Schull MJ, Brison R, Cass D, et al. Comparison
of the Canadian CT Head Rule and the New Orleans Criteria in patients with
minor head injury. JAMA 2005;294:1511e8.
[15] Smits M, Dippel DW, de Haan GG, Dekker HM, Vos PE, Kool DR, et al.
External validation of the Canadian CT Head Rule and the New Orleans
Criteria for CT scanning in patients with minor head injury. JAMA 2005;
294:1519e25.
[16] Carson J, Tator C, Johnston K, Kissick J, Purcell L, Hunt B. New guidelines for
concussion management. Can Fam Physician 2006;52:756e7.
[17] Wu X, Hu J, Zhuo L, Fu C, Hui G, Wang Y, et al. Epidemiology of traumatic brain
injury in eastern China, 2004: a prospective large case study. J Trauma 2008;
64:1313e9.
[18] Chiu WT, Huang SJ, Tsai SH, Lin JW, Tsai MD, Lin TJ, et al. The impact of time,
legislation, and geography on the epidemiology of traumatic brain injury.
J Clin Neurosci 2007;14:930e5.
[19] Thornhill S, Teasdale GM, Murray GD, McEwen J, Roy CW, Penny KI. Disability
in young people and adults one year after head injury: prospective cohort
study. BMJ 2000;320:1631e5.
[20] Roe C, Sveen U, Alvsaker K, Bautz-Holter E. Post-concussion symptoms
after mild traumatic brain injury: inﬂuence of demographic factors and
injury severity in a 1-year cohort study. Disabil Rehabil 2009;31:
1235e43.
[21] Sigurdardottir S, Andelic N, Roe C, Jerstad T, Schanke AK. Post-concussion
symptoms after traumatic brain injury at 3 and 12 months post-injury:
a prospective study. Brain Inj 2009;23:489e97.
[22] Bazarian JJ, Wong T, Harris M, Leahey N, Mookerjee S, Dombovy M. Epide-
miology and predictors of post-concussive syndrome after minor head injury
in an emergency population. Brain Inj 1999;13:173e89.
[23] King NS. Post-concussion syndrome: clarity amid the controversy?
Br J Psychiatry 2003;183:276e8.
[24] de Kruijk JR, Leffers P, Meerhoff S, Rutten J, Twijnstra A. Effectiveness of bed
rest after mild traumatic brain injury: a randomised trial of no versus six days
of bed rest. J Neurol Neurosurg Psychiatry 2002;73:167e72.
